Effects of Candesartan and HCTZ on Heart Health
Author Information
Author(s): Bramlage Peter, Schönrock Eleonore, Odoj Peter
Primary Institution: Institute for Clinical Pharmacology, Medical Faculty Carl Gustav Carus, TU Dresden, Germany
Hypothesis
Can a combination of candesartan and hydrochlorothiazide improve metabolic risk factors in patients with hypertension?
Conclusion
The study shows that a treatment combining candesartan and HCTZ significantly reduces blood pressure and improves metabolic risk factors.
Supporting Evidence
- Blood pressure was reduced by -27.2/-13.4 mmHg.
- Waist circumference was reduced and HDL-C elevated in every subgroup except the control subgroup.
- Fasting blood glucose was reduced by -5.6 ± 21.6%.
- Triglycerides were reduced by -4.9 ± 29.4%.
- The SCORE value was reduced substantially in patients with diabetes, metabolic syndrome, or neither.
Takeaway
This study found that a specific medicine combination can help lower blood pressure and make people healthier by improving their blood sugar and cholesterol levels.
Methodology
A non-interventional observational study conducted in Germany with patients having uncontrolled hypertension and at least one additional risk factor.
Potential Biases
Potential biases due to non-consecutive patient selection and lack of randomization.
Limitations
The study was not controlled, lacked randomization, and did not document changes in concomitant medications.
Participant Demographics
Patients were 62.2 years old on average, with 48.1% female and 97.5% having at least one additional risk factor.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website